Edwards Lifesciences Corporation is on the Cruelty Free Investing list for exploiting animals because the company does animal testing for some of their medical analysis and clinical research.
The company stated in the following press release that they conduct preclinical trials on animals.
“Based on animal studies, the ThermaFix dual-action process reduces tissue calcification by up to 81 percent over standard controls.” Read the full article.
Edwards Lifesciences Corp. engages in the design, development, manufacture, and markets products to treat stage cardiovascular disease. It operates through the following geographical segments: United States, Europe, Japan, and Rest of the World. Its products are categorized into three areas: Surgical Heart Valve Therapy, Transcatheter Heart Valves, and Critical Care. The Surgical Heart Valve Therapy portfolio includes tissue heart valves and heart valve repair products for the surgical replacement or repair of a patient’s heart valve. The Transcatheter Heart Valves portfolio includes technologies designed to treat heart valve disease using catheter-based approaches as opposed to open surgical techniques. The Critical Care portfolio products include pulmonary artery catheters, disposable pressure transducers and advanced monitoring systems. The company was founded by Miles Lowell Edwards in 1958 and is headquartered in Irvine, CA. [Source: MarketWatch]
Company Website: http://www.edwards.com